Ligand Pharmaceuticals Incorporated (LGND)
Jul 2, 2025 - LGND was delisted (reason: merged into PTHS)
113.30
+0.74 (0.66%)
Inactive · Last trade price on Jul 2, 2025
Ligand Pharmaceuticals Revenue
Ligand Pharmaceuticals had revenue of $45.33M in the quarter ending March 31, 2025, with 46.34% growth. This brings the company's revenue in the last twelve months to $181.49M, up 53.40% year-over-year. In the year 2024, Ligand Pharmaceuticals had annual revenue of $167.13M with 27.28% growth.
Revenue (ttm)
$181.49M
Revenue Growth
+53.40%
P/S Ratio
11.68
Revenue / Employee
$2,668,941
Employees
68
Market Cap
2.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 167.13M | 35.82M | 27.28% |
Dec 31, 2023 | 131.31M | -64.93M | -33.09% |
Dec 31, 2022 | 196.25M | -45.30M | -18.75% |
Dec 31, 2021 | 241.54M | 77.98M | 47.68% |
Dec 31, 2020 | 163.56M | 43.28M | 35.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLGND News
- 1 day ago - Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewsWire
- 9 days ago - Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 23 days ago - Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™ - GlobeNewsWire
- 4 weeks ago - Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement - GlobeNewsWire
- 4 weeks ago - Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics - GlobeNewsWire
- 5 weeks ago - Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward - Seeking Alpha
- 7 weeks ago - Ligand Announces 2025 Investor Day in New York City - GlobeNewsWire
- 2 months ago - Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - GlobeNewsWire